Doctors are warning that every minute counts – at least no more than 180 – for people experiencing a stroke, as new figures reveal persistently high incidence rates and a lack of urgent action is putting lives in jeopardy.

Consultant neurologist Dr Simeona Jacinto revealed during the season three finale of the Queen Elizabeth Hospital’s Pulse radio show on Monday that Barbados records approximately 1.4 strokes per 1 000 people, with 70 per cent of cases linked to high blood pressure and one in three patients also diabetic.

She stressed that stroke is the leading cause of long-term disability in the Caribbean and the second deadliest condition globally.

“The earlier you come for management, the more likely we can limit brain damage,” Dr Jacinto said, urging the public to remember the FAST acronym – face drooping, arm weakness, speech difficulty, time to call 511.

“The best stroke treatment is prevention – but if a stroke happens, act fast and call for help immediately.”

Consultant Emergency Physician Dr Anne-Marie Cruickshank. (FP)

Further underscoring the severity of the condition, consultant emergency physician Dr Anne-Marie Cruickshank, who heads the QEH Accident and Emergency Department, warned that doctors have just a three to four-hour window to administer life-saving treatment.

“Once symptoms begin, every second counts. The ambulance is your best option – they alert us ahead so we can be ready the moment you arrive,” she said.

The doctors also dispelled dangerous myths still common in the community, including the belief that strokes cannot be treated or should be managed at home with old remedies like nutmeg or Bible readings.

“We’ve moved past that,” Dr Cruickshank said. “We now have treatments like thrombolysis that can prevent further brain damage and even reverse some of the deficits.”

She also encouraged the public to enrol in emergency response training offered by the Heart and Stroke Foundation, including Heart Saver and Basic Life Support (BLS) courses.

“We need more people trained and more instructors. Public involvement is crucial,” she said. 

(SM)

The post Stroke response delays putting lives at risk, say doctors appeared first on Barbados Today.

In the past year alone, 13 CARPHA Member States reported over 2,569 suspected and 1,295 laboratory-confirmed dengue cases — a 16% increase over the previous year

View the full post Caribbean Mosquito Awareness Week 2025 on NOW Grenada.

The news triggered a shutdown of cattle, horse and bison imports along the southern border, as U.S. Department of Agriculture (USDA) Secretary Brooke Rollins announced in an X post on Sunday.

"Due to the threat of New World Screwworm I am announcing the suspension of live cattle, horse, & bison imports through U.S. southern border ports of entry effective immediately," she wrote in the post. 

DANGEROUS FUNGUS COULD SPREAD TO PARTS OF US, RESEARCHERS CLAIM

"The last time this devastating pest invaded America, it took 30 years for our cattle industry to recover. This cannot happen again."

The NWS is a fly that is endemic in Cuba, Haiti, the Dominican Republic and some South American countries, according to the USDA's Animal and Plant Health Inspection Service (APHIS).

While the flies themselves are found in forests and other wooded areas, they will seek hosts like cattle or horses in pastures and fields, per the above source.

A female fly lays eggs in a wound or orifice of a live, warm-blooded animal. The eggs then hatch into larvae (maggots) that burrow into the flesh, causing potentially deadly damage.

MEASLES SCARE AT MAJOR AIRPORT: WHAT TO KNOW ABOUT POTENTIAL EXPOSURE

Screwworms are named for their maggots’ behavior, as they burrow into the flesh similar to how a screw is driven into wood.

"Maggots cause extensive damage by tearing at the hosts’ tissue with sharp mouth hooks," according to the APHIS website. This can then enlarge the wound and attract more flies to lay eggs.

In rare cases, the larvae can feed on people, the Centers for Disease Control and Prevention states.

These infestations can be very painful and can cause serious, potentially fatal damage to their hosts by causing myiasis, a parasitic infection of fly larvae in human tissue. 

Screwworms are often found in South America and the Caribbean.

For more Health articles, visit www.foxnews.com/health

"People who travel to these areas, spend time among livestock animals, sleep outdoors and have an open wound are at greater risk of becoming infested with NWS," says the CDC.

People who are immunocompromised, very young or very old, or malnourished are also at a higher risk of infection, the above source stated.

Those who have had recent surgery are also at a higher risk, "as the flies will lay eggs on open sores," according to the CDC.

If another outbreak were to occur in the U.S., "pets, livestock, wildlife and even humans may suffer and die from screwworm myiasis," the USDA warned.

The USDA estimates that livestock producers in the southwestern U.S. lost between $50 million and $100 million annually due to NWS in the 1950s and 1960s until it was successfully eradicated.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"Presumably, these higher losses in the Southwest were due to higher livestock populations, larger geographic area and/or greater potential for NWS to overwinter," stated the report.

While the USDA eradicated NWS in 1966, there was an outbreak contained within the Florida Keys in 2016. It affected only in the endangered deer population and was eradicated by March 2017, per APHIS.

Greg Wehner of Fox News Digital contributed reporting.

On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices in the U.S., the spotlight is on current costs and how much Americans could save.

The president’s order calls for "most favored nations drug pricing" — which means "the lowest price paid for a drug in other developed countries, that is the price that Americans will pay," he said.

"Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%," Trump said. 

PRESIDENT TRUMP TAKES ON 'BIG PHARMA' BY SIGNING EXECUTIVE ORDER TO LOWER DRUG PRICES

Katy Dubinsky, a New York pharmacist and founder and CEO of Vitalize, applauded the move to reduce prescription prices, noting that Trump’s order tackles a long-standing problem.

"But this will not be simple to accomplish," she told Fox News Digital. 

"The executive order doesn't reduce costs immediately," she said. "It directs government agencies to start drafting the rules, which may take months."

Here are the five most expensive prescription drugs in the U.S. by price — followed by five by volume.

Dubinsky detailed some of the most expensive prescription drugs in the country today and what conditions they treat.

1.  Lenmeldy (atidarsagene autotemcel) by Orchard Therapeutics – $4.25 million

This medication is used to treat metachromatic leukodystrophy (MLD), a rare genetic disorder that damages the nervous system, Dubinsky said. 

"It is given once and is supposed to stop or slow down the disease in young kids," she noted.

TOP 10 'ALLERGY CAPITALS' OF THE US, PLUS 4 TIPS TO MANAGE SYMPTOMS

2. Hemgenix (etranacogene dezaparvovec-drlb) by CSL Behring – $3.5 million

This medication is prescribed for people with hemophilia B, a bleeding disorder. 

"This one-time treatment helps the body make its own clotting factor, so patients don’t need regular infusions," said Dubinsky.

3. Elevidys (delandistrogene moxeparvovec-rokl) by Sarepta Therapeutics – $3.2 million

This prescription medication, intended for young boys, treats Duchenne muscular dystrophy (DMD), a condition that weakens muscles over time. 

"It aims to slow down how fast the disease progresses," Dubinsky said. 

4. Skysona (elivaldogene autotemcel) by Bluebird Bio – $3 million

"This medication is used for cerebral adrenoleukodystrophy (CALD), a serious brain disease in boys," said Dubinsky. "This therapy tries to slow the damage before symptoms get worse."

5. Zynteglo (betibeglogene autotemcel) by Bluebird Bio – $2.8 million

Zynteglo is for beta-thalassemia, a blood condition that usually requires regular transfusions. 

"This gene therapy can help patients make healthy red blood cells on their own and reduce how often they need treatment," said Dubinsky.

John Stanford, executive director of Incubate, a Washington-based coalition of early-stage life-science investors, shared his thoughts on the top five most expensive drugs by sales volume.

"Typically, when the government is focused on the most expensive drugs, they're focused on the metric based on sales volume rather than, for instance, a rare disease therapy with a high list price but smaller patient pool," he told Fox News Digital.

"Often, officials are focused on total drug spending by Medicare or other government programs."

1. Keytruda (pembrolizumab) by Merck — $25 billion revenue (2023)

Keytruda is an immunotherapy medication used to treat a variety of cancers, including melanoma, non-small cell lung cancer, liver cancer and others.

"Keytruda has become Merck's crown jewel, helping the company expand its cancer treatment portfolio with more than 1,000 active clinical trials," Stanford told Fox News Digital.

TERMINAL COLON CANCER PATIENT SAVED BY BREAKTHROUGH TREATMENT

2. Eliquis (apixaban) by Bristol Myers Squibb and Pfizer — $18.95 billion

Eliquis (apixaban) is an "anchor drug" for both BMS and Pfizer, according to Stanford.

Apixaban is prescribed to prevent the formation of blood clots and to treat deep vein thrombosis and pulmonary embolism (a blood clot in the lungs). 

3. Ozempic (semaglutide) by Novo Nordisk — $13.93 billion

Prescribed for type 2 diabetes, the semaglutide medication Ozempic has become widely popular for its weight-loss effects and other health benefits.

"Ozempic's sales are powering Novo Nordisk's broader foray into GLP-1s for obesity, heart disease and liver conditions — all areas with high development costs and uncertain scientific outcomes," Stanford told Fox News Digital. 

"The money has gone toward scaling up production to meet demand for GLP-1s and avoid supply shortages."

4. Humira (AbbVie) — $14.4 billion (U.S. 2023 revenue)

"Humira has been one of the highest-grossing drugs in history, generating over $200 billion during its exclusivity period," Stanford said.

The injectable medication, which contains the active ingredient adalimumab, is used to treat rheumatoid arthritis and other inflammatory conditions.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

5. Biktarvy by Gilead — $11.85 billion

Biktarvy is an HIV treatment that includes the three ingredients bictegravir, emtricitabine and tenofovir alafenamide.

"Biktarvy isn't just a leading HIV treatment — it's the financial backbone for Gilead's move into cancer research," Stanford said.

Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, said vaccines and most generic drugs would not likely be changed by the executive order.

"Most vaccines that Americans take cost less than a hundred dollars, while generic drugs are often less than a dollar a pill," he told Fox News Digital.

What would be affected, Glanville predicted, are newer brand-name drugs still under IP exclusivity, antibody therapies, cellular therapies, gene therapies and personalized cancer vaccines.

"Some of these are excruciatingly expensive — $100,000 to $500,000 for a treatment course for a patient. However, they are also often the most effective treatments for certain cancers, autoimmune disorders or rare diseases."

The pharmaceutical industry might argue that lowering the prices on these medicines will result in a "dramatic reduction of investment" in creating such breakthroughs, said Glanville.

The industry may also argue that these medicines eventually become generic — at which point the prices drop, according to the expert.

For more Health articles, visit www.foxnews.com/health

"From a patient’s perspective, the price of medical care in the United States is unsustainable, and extremely expensive medicine is part of that," he said. But "the insurance system and the hospital business also contribute."

"If the prices of new medicines are capped, then effort should be made to reduce the cost of clinical trials and drug GMP manufacturing. Otherwise, we will lose a lot of innovation."

Greg Norman of Fox News Digital contributed reporting.

The GFNC congratulates winners Carona Mitchell, Roselyn Thomas and Roxanne Thomas, and all participants for showing that healthy shopping can be both strategic and fun

View the full post GFNC’s Supermarket Sweep winners on NOW Grenada.

To strengthen dengue prevention and control, the Ministry of Public Health (MSP) has acquired new fumigation backpacks, which have been delivered to the 40 Provincial Health Directorates and Health Areas (DPS/DAS) throughout the country.

Impact of the measure

Health Minister Víctor Atallah stressed that this initiative seeks to further reduce the incidence of dengue compared to 2024 when a decrease of more than 350% was achieved thanks to preventive strategies.

Atallah recalled that this success was due to the “Eliminate, Clean, and Cover” campaign, which included garbage collection, cleaning, fumigation, education, and awareness about the importance of eliminating breeding sites for the Aedes aegypti mosquito, which transmits dengue.

International recognition

The minister highlighted that international organizations have recognized the Dominican Republic’s success in fighting dengue and have shown interest in replicating these strategies in other countries.

“By combating dengue in 2024, we achieved what other countries and international organizations thought was not possible,” Atallah said.

Commitment to prevention

The deputy minister of the Provincial Health Directorates, Luis Nelson Rosario, assured that they will continue working to ensure that dengue control results are even better in 2025.

Rosario thanked Minister Atallah for the delivery of the fumigation motorcycles, a key tool for preventing mosquito reproduction, along with other measures such as the use of abate and chlorine.

“If we work together with local councils and social groups, we will be able to maintain low levels of dengue and other diseases,” he added.

Presence of authorities

The handover ceremony was attended by the deputy ministers of Public Health, Eladio Pérez, Risk Management and Environment, Gina Estrella, the provincial health directors, and other Ministry officials.

View the full post Ministry of Health dismisses Sauteurs Health Centre rumours on NOW Grenada.

“Caricom must chart a new course for public health resilience,” underscored the Chair, Dr Shawn Charles, Chief Medical Officer of Grenada

View the full post Caricom chief medical officers chart new course on NOW Grenada.

Santo Domingo.- The Ministry of Public Health announced a marked decline in dengue cases this year, with only 83 reported so far—down from 818 during the same period in 2024. This brings the incidence rate to 2.36 cases per 100,000 people. Officials credit the drop to aggressive and coordinated preventive actions led by provincial health directorates and supported by multiple sectors.

Other diseases, including cholera, leptospirosis, and vaccine-preventable illnesses like polio, rubella, and measles, have remained at minimal levels. Malaria also saw a notable reduction, with four new cases reported this week for a total of 184 in 2025—over 57% fewer than last year. The Ministry attributes this progress to efforts by Cecovez and the National Malaria Program aimed at achieving full elimination of the disease.

In maternal and infant health, three maternal deaths were recorded this week—two Haitian and one Dominican—bringing the total to 54 this year, compared to 66 in 2024. Infant deaths also declined slightly, with 30 reported this week and a total of 562 for the year, down from 633 at the same point last year.

View the full post Food security and nutrition in focus at statistics workshop on NOW Grenada.